# NeuroKaire

**Source:** https://www.startuphub.ai/startups/genetika
**Profile type:** Startup

> Personalized medical testing tool to optimize drug therapy for depression.

## About

NeuroKaire transforms depression medication selection by understanding how each patient's unique brain and body responds to medication, moving beyond trial-and-error. Their service helps evaluate how different antidepressants are likely to interact with a person's brain biology before treatment starts, guiding treatment choices with greater confidence. NeuroKaire serves both patients and providers.

## Key facts

- **Slug:** genetika
- **Website:** http://www.genetikaplus.com
- **Location:** Tel Aviv, Israel
- **Founded:** 2017-10-01 00:00:00
- **Employees:** 36
- **Operating status:** Active
- **Total funding:** $27M
- **Sectors / tags:** Neuroscience, Biotech, Mental Health, Drug Therapy, Depression, Personalized Treatment, Next Generation Sequencing, HealthTech, MedTech, Mental Health Tech, Genomics, Precision Medicine, Drug Discovery
- **Social:**
  - LinkedIn: https://www.linkedin.com/company/genetika/
  - Twitter: https://x.com/neurokaire
  - Facebook: https://www.facebook.com/neurokaire

## Frequently asked

### What does NeuroKaire do?

NeuroKaire transforms depression medication selection by understanding how each patient's unique brain and body responds to medication, moving beyond trial-and-error. Their service helps evaluate how different antidepressants are likely to interact with a person's brain biology before treatment starts, guiding treatment choices with greater confidence. NeuroKaire serves both patients and providers. (formerly Genetika+.)

### What is NeuroKaire's revenue?

StartupHub estimates NeuroKaire's annual revenue at $28.6M (range $15.4M to $33.5M, 62% confidence), based on comparable companies in the sector.

### What is NeuroKaire's valuation?

StartupHub estimates NeuroKaire's effective valuation at $113.0M (range $68.3M to $163.8M, 10% confidence), based on comparable companies in the sector.

### How much funding has NeuroKaire raised?

NeuroKaire has raised a total of $27M in funding. The most recent round on record is Grant.

### Where is NeuroKaire headquartered?

NeuroKaire is headquartered in Tel Aviv, Israel.

### When was NeuroKaire founded?

NeuroKaire was founded in 2017.

### What industry does NeuroKaire operate in?

NeuroKaire operates in Neuroscience, Biotech, Mental Health, Drug Therapy, Depression, Personalized Treatment.

### How many employees does NeuroKaire have?

NeuroKaire has approximately 36 people on record.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "NeuroKaire",
          "item": "https://www.startuphub.ai/startups/genetika"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/genetika#webpage",
      "url": "https://www.startuphub.ai/startups/genetika",
      "name": "NeuroKaire - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of NeuroKaire (formerly Genetika+). NeuroKaire is a startup founded in 2017, operating in Neuroscience and Biotech. Personalized medical testing tool to optimize drug therapy for depression. Headquartered in Tel Aviv, Israel. The company has approximately 36 employees.",
      "dateModified": "2026-07-01T09:30:43.137864+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/genetika#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/genetika#organization",
      "name": "NeuroKaire",
      "url": "http://www.genetikaplus.com",
      "logo": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/d0413b25-7e89-41cc-a808-b3f9444cc32e-square.webp",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/d0413b25-7e89-41cc-a808-b3f9444cc32e-square.webp",
      "description": "This is the official profile of NeuroKaire (formerly Genetika+). NeuroKaire is a startup founded in 2017, operating in Neuroscience and Biotech. Personalized medical testing tool to optimize drug therapy for depression. Headquartered in Tel Aviv, Israel. The company has approximately 36 employees.",
      "sameAs": [
        "https://www.linkedin.com/company/genetika/",
        "https://x.com/neurokaire",
        "https://www.facebook.com/neurokaire",
        "https://www.startuphub.ai/startups/genetika"
      ],
      "foundingDate": "2017-10-01 00:00:00",
      "numberOfEmployees": {
        "@type": "QuantitativeValue",
        "value": 36
      },
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Tel Aviv",
        "addressCountry": "Israel"
      },
      "knowsAbout": [
        "Neuroscience",
        "Biotech",
        "Mental Health",
        "Drug Therapy",
        "Depression",
        "Personalized Treatment",
        "Next Generation Sequencing",
        "HealthTech",
        "MedTech",
        "Mental Health Tech",
        "Genomics",
        "Precision Medicine",
        "Drug Discovery"
      ]
    }
  ]
}
```